RxDoctor Payments Data

Haleigh Poe, PA

Physician Assistant · Connersville, INNPI 1023724655

Payments from drug & device makers

$1,371in general payments, 2019–2025

Across 91 payments — averaging $15.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$343
  • Vanda Pharmaceuticals Inc.$288
  • AbbVie$168
  • Otsuka America Pharmaceutical, Inc.$118
  • Novo Nordisk$96
  • Axsome Therapeutics, Inc.$70
  • plus $289 from 10 others

What the payments were for

  • Food & beverage$1,27693%
  • Education$957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,371 in reported general payments places this provider in the 80th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$22,220
Medicare patients
79
Services billed
338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$46,678
JardianceEmpagliflozin30$30,825
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$22,151
EliquisApixaban11$14,779
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,162
Breo ElliptaFluticasone/Vilanterol11$4,350
Atorvastatin Calcium112$1,238
Albuterol Sulfate HfaAlbuterol Sulfate53$1,052
Levothyroxine Sodium97$1,000
Diclofenac Sodium27$980
Omeprazole100$882
Duloxetine Hcl23$793
Hydroxyzine Hcl21$726
Buspirone Hcl27$639
Bupropion XlBupropion Hcl17$551

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$96$46,67840 claims
GSKTrelegy Ellipta, Breo Ellipta$14$26,50123 claims
PfizerEliquis$57$14,77911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Connersville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →